Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial - Godet, C; Couturaud, F; Marchand-Adam, S; NebuLamB study group and GREPI network (Eur Respir J, 2022)